Critical role of EphA3 in cancer and current state of EphA3 drug therapeutics
Author:
Funder
Charles H. Best Foundation
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11033-020-05571-8.pdf
Reference131 articles.
1. Gschwind A, Fischer OM, Ullrich A (2004) The discovery of receptor tyrosine kinases: targets for cancer therapy. Nat Rev Cancer 4(5):361–370. https://doi.org/10.1038/nrc1360
2. Carpenter G, Lembach KJ, Morrison MM, Cohen S (1975) Characterization of the binding of 125-I-labeled epidermal growth factor to human fibroblasts. J Biol Chem 250(11):4297–4304
3. Schlessinger J (2014) Receptor tyrosine kinases: legacy of the first two decades. Cold Spring Harb Perspect Biol 6(3):a008912. https://doi.org/10.1101/cshperspect.a008912
4. Kasuga M, Zick Y, Blithe DL, Crettaz M, Kahn CR (1982) Insulin stimulates tyrosine phosphorylation of the insulin receptor in a cell-free system. Nature 298(5875):667–669. https://doi.org/10.1038/298667a0
5. Czech MP (1982) Structural and functional homologies in the receptors for insulin and the insulin-like growth factors. Cell 31(1):8–10
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ephs in cancer progression: complexity and context-dependent nature in signaling, angiogenesis and immunity;Cell Communication and Signaling;2024-05-29
2. UGT1A1 variants contribution to neonatal hyperbilirubinemia: evidence from whole exome sequencing Running title: UGT1A1 variants contribution to neonatal hyperbilirubinemia;2024-01-03
3. Antibody drug conjugates for glioblastoma: current progress towards clinical use;Expert Opinion on Biological Therapy;2023-11-02
4. Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma;Journal for ImmunoTherapy of Cancer;2023-11
5. Knockdown of circ_CLIP2 regulates the proliferation, metastasis and apoptosis of glioma cells through miR-641/EPHA3/STAT3 axis;Journal of Neurogenetics;2023-04-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3